https://orcid.org/0000-0001-9084-8598
Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Karen Beny, Benjamin du Sartz de Vigneulles, Valerie Chamouard, Ronald Guilloux, Valérie Gay, Claude Negrier & Claude Dussart. (2021) Patients’ Perception of the Impact of Innovation on Hemophilia Care Management Organization: A Qualitative Study Protocol (INNOVHEMO Study). Patient Preference and Adherence 15, pages 1807-1815.
Read now
Read now
Articles from other publishers (4)
Jan Astermark, Jan Blatný, Christoph Königs, Cédric Hermans, Victor Jiménez-Yuste & Daniel P. Hart. (2023) Considerations for shared decision management in previously untreated patients with hemophilia A or B. Therapeutic Advances in Hematology 14, pages 204062072311658.
Crossref
Crossref
Karen Beny, Amélie Dubromel, Benjamin du Sartz de Vigneulles, Valérie Gay, Florence Carrouel, Claude Negrier & Claude Dussart. (2022) Multiple criteria decision analysis for therapeutic innovations in a hemophilia care center: A pilot study of the organizational impact of innovation in hemophilia care management. PLOS ONE 17:9, pages e0273775.
Crossref
Crossref
Emine Türkkan, Gül Nihal Özdemir, Öykü Arslan, Serap Karaman, Zeynep Karakaş & Ayşegül Ünüvar. (2022) Improved clinical outcome after PK-Guided Personalised Prophylaxis with my-PKFIT® in patients with hemophilia A without inhibitors. Medical Science and Discovery 9:2.
Crossref
Crossref
Paolo Angelo Cortesi, Adele Giampaolo, Francesca Abbonizio, Angelo Claudio Molinari, Giancarlo Castaman, Mauro Biffoni & Lorenzo Giovanni Mantovani. (2021) Variability of treatment modalities and intensity in patients with severe haemophilia A on prophylaxis: Results from the Italian national registry. European Journal of Haematology 107:4, pages 408-415.
Crossref
Crossref